Status:
COMPLETED
Handheld Ultrasound (HHUS) for Home Use in Hemophilia
Lead Sponsor:
Washington Institute for Coagulation
Collaborating Sponsors:
Genentech, Inc.
Conditions:
Joint Bleed
Hemophilia A
Eligibility:
MALE
18+ years
Brief Summary
This is a study in 3 phases that will assess the feasibility and utility of handheld home ultrasound (HHUS) in a patient's home to assess whether a painful episode in the elbow, knee or ankle is a ble...
Detailed Description
This is a study in 3 phases that will assess the feasibility and utility of handheld home ultrasound (HHUS) in a patient's home to assess whether a painful episode in the elbow, knee or ankle is a ble...
Eligibility Criteria
Inclusion
- Severe hemophilia A
- Male
- Over 18 years of age
- Able to read, write and understand English
- Willing to come to the center for an 8 hour training session
- Lives in proximity of the HTC and is willing to come in for acute joint episodes in phase 2
- Willing and able to follow study procedures
- Willing and able to keep HHUS at a safe place
- Have the dexterity to operate a HHUS unit
Exclusion
- Unable to follow study instructions
- Physically or mentally unable to operate a HHUS unit
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 22 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04131920
Start Date
October 1 2019
End Date
June 22 2022
Last Update
June 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington Center for Bleeding Disorders at Washington Institute for Coagulation
Seattle, Washington, United States, 98101